Atlas Trials

Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL

Clinical trial NCT05571540 · WITHDRAWN

Trial details

NCT number
NCT05571540
Sponsor
Kunming Hope of Health Hospital
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
B-cell Acute Lymphoblastic LeukemiaB-ALL
Start date
2022-10-01
Primary completion
2024-01-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.